Phenobarbitone: Difference between revisions
Populate pages with audio |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Category: Drugs]] | [[Category: Drugs]] [[Category: Anticonvulsant medication]] | ||
'''Phenobarbital'''(中文: [[苯巴比妥]]), also known as phenobarbitone or phenobarb, is a medication of the barbiturate type. It is used to control all forms of epilepsy except absence seizures. It is also used as part of the emergency management of acute seizures including status epilepticus. | |||
It usually begins working within 5 minutes when used intravenously and 30 minutes when administered by mouth. Its effects last for between 4 hours and 2 days. | |||
==Pronunciation== | ==Pronunciation== | ||
===Phenobarbitone 30mg=== | ===Phenobarbitone 30mg=== | ||
| Line 6: | Line 10: | ||
===Phenobarbitone 60mg=== | ===Phenobarbitone 60mg=== | ||
[[File:Phenobarbitone 60mg.mp3]] | [[File:Phenobarbitone 60mg.mp3]] | ||
==Drug Names== | |||
{| class="wikitable" | |||
!Generic Name 藥名 | |||
!HA Code 藥物代碼 | |||
!Classification藥物分類 | |||
|- | |||
|Phenobarbitone Tablet 30mg | |||
|PHEN08 | |||
|P1S1S3 | |||
|- | |||
|Phenobarbitone Tablet 60mg | |||
|PHEN09 | |||
|P1S1S3 | |||
|} | |||
==Mechanism of Action== | |||
Anticonvulsant medication. It binds to GABAa receptor subunits. Through this interaction, phenobarbitone increases the flow of chloride ions into the neuron which decreases the excitability of the post-synaptic neuron. Furthermore, direct blockade of excitatory glutamate signaling also contribute to the hypnotic/anticonvulsant effect. | |||
==Dosage== | |||
The dose should be adjusted to the needs of the individual patient to achieve control of seizures; this usually requires plasma concentrations of 15 to 40 micrograms/ml. However, plasma-drug concentration monitoring is less useful than with other drugs because tolerance occurs. | |||
{|class="wikitable" | |||
!style="text-align: left"| Epilepsy | |||
|''By Mouth | |||
ADULT: | |||
*60 – 180 mg once daily, dose to be taken at night | |||
CHILD 1 month – 11 years: | |||
*Initially 1 – 1.5 mg/kg twice daily, then | |||
*Increased in steps of 2 mg/kg daily as required; | |||
*Maintenance 2.5 – 4 mg/kg in 1 – 2 times daily | |||
CHILD 12 – 17 years: | |||
*60 – 180 mg once daily, dose to be taken at night | |||
|- | |||
!style="text-align: left"| Status epilepticus | |||
|''By intravenous injection | |||
ADULT: | |||
*10 mg/kg (max. per dose 1g), dose to be administered at a rate not more than 100 mg/minute, injection to be diluted 1 in 10 with water for injections. | |||
By slow intravenous injection | |||
CHILD 1 month – 11 years: | |||
*Initially 20 mg/kg, dose to be administered at a rate no faster than 1 mg/kg/minute, then | |||
*2.5 – 5 mg/kg 1 -2 times a day | |||
CHILD 12 – 17 years: | |||
*Initially 20 mg/kg (max. per dose 1g), dose to be administered at a rate no faster than 1 mg/kg/minute, then | |||
*300 mg twice daily | |||
|} | |||
Revision as of 21:28, 7 October 2020
Phenobarbital(中文: 苯巴比妥), also known as phenobarbitone or phenobarb, is a medication of the barbiturate type. It is used to control all forms of epilepsy except absence seizures. It is also used as part of the emergency management of acute seizures including status epilepticus.
It usually begins working within 5 minutes when used intravenously and 30 minutes when administered by mouth. Its effects last for between 4 hours and 2 days.
Pronunciation
Phenobarbitone 30mg
Phenobarbitone 60mg
Drug Names
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Phenobarbitone Tablet 30mg | PHEN08 | P1S1S3 |
| Phenobarbitone Tablet 60mg | PHEN09 | P1S1S3 |
Mechanism of Action
Anticonvulsant medication. It binds to GABAa receptor subunits. Through this interaction, phenobarbitone increases the flow of chloride ions into the neuron which decreases the excitability of the post-synaptic neuron. Furthermore, direct blockade of excitatory glutamate signaling also contribute to the hypnotic/anticonvulsant effect.
Dosage
The dose should be adjusted to the needs of the individual patient to achieve control of seizures; this usually requires plasma concentrations of 15 to 40 micrograms/ml. However, plasma-drug concentration monitoring is less useful than with other drugs because tolerance occurs.
| Epilepsy | By Mouth
ADULT:
CHILD 1 month – 11 years:
CHILD 12 – 17 years:
|
|---|---|
| Status epilepticus | By intravenous injection
ADULT:
By slow intravenous injection CHILD 1 month – 11 years:
CHILD 12 – 17 years:
|
